A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of differen...

por Dierig, A, Hoelscher, M, Schultz, S, Hoffmann, L, Jarchow-MacDonald, A, Svensson, EM, Te Brake, L, Aarnoutse, R, Boeree, M, McHugh, TD, Wildner, LM, Gong, X, Phillips, PPJ, Minja, LT, Ntinginya, N, Mpagama, S, Liyoyo, A, Wallis, RS, Sebe, M, Mhimbira, FA, Mbeya, B, Rassool, M, Geiter, L, Cho, YL, Heinrich, N
Publicado 2023

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

por Tweed, C. D., Wills, G. H., Crook, A. M., Amukoye, E., Balanag, V., Ban, A. Y.L., Bateson, A. L.C., Betteridge, M. C., Brumskine, W., Caoili, J., Chaisson, R. E., Cevik, M., Conradie, F., Dawson, R., del Parigi, A., Diacon, A., Everitt, D. E., Fabiane, S.M., Hunt, R., Ismail, A. I., Lalloo, U., Lombard, L., Louw, C., Malahleha, M., McHugh, T. D., Mendel, C. M., Mhimbira, F., Moodliar, R. N., Nduba, V., Nunn, A. J., Sabi, I., Sebe, M. A., Selepe, R. A. P., Staples, S., Swindells, S., van Niekerk, C. H., Variava, E., Spigelman, M., Gillespie, S. H.
Publicado 2021